| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-11 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.22 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-12 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.23 | 9e-13 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.25 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.25 | 5e-05 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.26 | 0.07 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.26 | 0.4 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.27 | 6e-15 |